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Abstract
Objectives To evaluate the accuracy and speed of a novel
robotic technique as an aid to perform magnetic resonance
image (MRI)-guided prostate biopsies on patients with
cancer suspicious regions.
Methods A pneumatic controlled MR-compatible manipulator
with 5 degrees of freedom was developed in-house to guide
biopsies under real-time imaging. From 13 consecutive biopsy
procedures, the targeting error, biopsy error and target displace-
ment were calculated to evaluate the accuracy. The time was
recorded to evaluate manipulation and procedure time.
Results The robotic and manual techniques demonstrated
comparable results regarding mean targeting error (5.7 vs
5.8 mm, respectively) and mean target displacement (6.6 vs
6.0 mm, respectively). The mean biopsy error was larger
(6.5 vs 4.4 mm) when using the robotic technique, although
not significant. Mean procedure and manipulation time
were 76 min and 6 min, respectively using the robotic
technique and 61 and 8 min with the manual technique.
Conclusions Although comparable results regarding accura-
cy and speed were found, the extended technical effort of the
robotic technique make the manual technique – currently –
more suitable to perform MRI-guided biopsies. Furthermore,
this study provided a better insight in displacement of the
target during in vivo biopsy procedures.
Keywords Transrectal.Prostate.MR-guided.Biopsy.
Robot
Introduction
The detection rate of prostate cancer (PCa) in men with
elevated and/or rising prostate specific antigen (PSA)
after negative transrectal ultrasound -guided biopsy
(TRUS-Bx) sessions is poor. Hambrock et al. found a
cancer detection rate of 59%, in men with an elevated
PSA and multiple negative TRUS-Bx (≥2) sessions, for
magnetic-resonance guided biopsies (MRGBx). This is
an improvement when compared to 8 to 12-core TRUS-
Bx schemes with a detection rate around 17% (TRUS-Bx≥1)
[1–3]. Nevertheless, MRGBx is unpleasant for the
patient and time-consuming for the radiologist. For
these reasons an in-house pneumatically actuated MR-
compatible robot was developed where needle-guide
direction can be controlled in real-time inside the
controller room [4]. Consequently, the patient remains inside
the scanner bore. This may decrease procedure time, enhance
patient comfort and improve needle-guide positioning.
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DOI 10.1007/s00330-011-2259-3Eighty-percent of the tumors with a volume larger than
0.5 cm
3 (diameter=1.0 cm) are likely to be clinically
significant [5]. Therefore, it is desirable to have a technique
with a biopsy error smaller than 5 mm. Different factors,
such as needle-guide positioning, patient and prostate
motion, and tissue deformation influence the accuracy of
needle positioning [6–8]. Consequently, the needle does not
always reach the cancer suspicious region (CSR).
In a phantom study the new robotic technique
demonstrated a short manipulation time of 5 min (range
3–8 min) and a high accuracy of 3.0 mm (range 0–5.6 mm)
for needle positioning [4]. Yakar et al. demonstrated that it
is technical feasible to perform transrectal prostate biopsies
using the novel robotic technique (n=10) (Fig. 1)[ 9]. To
evaluate and optimize the biopsy procedure in the future, it
is necessary to identify and quantify the cause of the biopsy
error. Therefore, the purpose of this study was to evaluate
the accuracy and speed of the novel robotic technique as an
aid to perform MRGBx on patients with CSRs.
Materials and methods
Patients
This study was approved by the ethics review board and
written informed consent was obtained from all patients
who were biopsied with the robotic technique. From
February to September 2010, 13 consecutive patients with
an elevated PSA (>4 ng/mL) and at least one negative
TRUS-Bx session were included. Patient were included in
the robotic patient population based on their willingness.
The manual patient population was matched to the robotic
population. Prior to the MRGBx, patients received a 3 T
(Magnetom TRIO, Siemens, Germany) multi-parametric
MRI examination of the prostate for identification of
possible CSRs. T2-weighted (T2-w) images in three
orthogonal planes, transversal diffusion weighted images
(DWI) and dynamic contrast-enhanced (DCE)-MR images
(Table 1) were obtained during and after injection of 15 ml
gadopentetate dimeglumine with a power injector (Guerbet,
Gorinchem, Netherlands). To evaluate the CSR for clinical
significance, the criteria for MRGBx reported by Hambrock
et al. were applied [3].
CSRs were determined in consensus by 2 readers with at
least 6 years of experience in prostate MR reading. From
each CSR the volume (in cc) was determined on the MR
images, assuming that the lesions were ellipsoids.
MRGBx
MRGBx were performed within 12 weeks after the diagnostic
multi-parametric MR examination. Antibiotic prophylaxis
was given with 500 mg ciprofloxacin in the morning and
evening for three consecutive days, starting the day before
biopsy. A schematic representation of the steps taken to
perform a biopsy is illustrated in the flow chart (Fig. 2).
A needle-guide filled with gadolinium-doped water was
inserted in the rectum of the patient. Subsequently, the
needle-guide was mounted to the robotic or manual device
(Step 1). The MR imaging protocol (Step 2) for target
selection and to navigate on during the biopsy procedure is
shown in Table 1.
Targets were selected (Step 3) on these images based on
the CSRs found in the diagnostic MRI examination.
Manipulation of the needle-guide was done using either
the robotic or manual technique (Step 5). After correct
alignment of the needle-guide the insertion depth of the
needle was measured on a transversal true-FISP (TRUFI)
image (Table 1). The patient was slid out the gantry to
Fig. 1 a the robot with (1) the needle guide, (2) safety mechanism
with the suction cup, (3) tapping mechanism to introduce the needle
guide, (4) pneumatic motor, (5) tubings to the motors, (6) ground plate
for installation on the MR table, (7) angulation rail to move the needle
guide in the coronal plane. b set-up of a patient with the robotic
technique on the table of the MR system. The patient was positioned
in prone position in the MR system. After the needle guide was
inserted rectally it was attached to the robot
Eur Radiol (2012) 22:476–483 477insert the biopsy needle manually (titanium 18-gauge, fully
automatic, core-needle, double-shot biopsy gun with needle
length of 175, sampling length of 17 mm (Invivo,
Schwerin, Germany).
A T2-w 3D volumetric gradient-echo (first two proce-
dures with the robotic technique) or a T2-w 3D volumetric
spin-echo image (all other patients) was acquired with the
needle inserted (Step 7). This was the same 3D volumetric
image (Table 1) as acquired in step 2. When the needle was
in correct position, confirmed on the control images,
another target could be targeted (Steps 3–8) or the patient
was removed from the MR table (Step 9).
Needle-guide positioning: robotic technique
Theroboticsystemhasfivedegreesoffreedom:translationsin
three directions (anterior-posterior, inferior-superior, lateral)
and rotations in two directions (inferior-superior, lateral). The
angle of the needle-guide with the main magnetic field could
range from 30° to 55° in the inferior-superior direction and
plus or minus 26° in the lateral direction [4].
With a simple graphical user interface the direction
of the needle-guide can be adjusted [9]. A software
package (Interactive Front End (IFE); Siemens Corporate
Research, Baltimore (MD), USA) was used to orient and
direct the needle-guide in the desired direction (Step 5)
under real-time image guidance (Table 1). Manipulation of
images and relevant controls can be performed during
imaging which allows interactive slice positioning for path
planning and real-time monitoring [10, 11].
Needle-guide positioning: manual technique
Transversal and sagittal TRUFI images (Table 1)
through the needle-guide were acquired to determine
needle-guide direction. The patient was withdrawn from
the scanner bore and the radiologist manually adjusted
the biopsy device to point the needle-guide towards the
Table 1 Imaging protocol with sequence specifications. Volumetric images were utilized to identify anatomical landmarks used to quantify target
displacement. * The initial two volumetric images (2/13) were gradient echo sequences (first 2 procedures using the robotic technique)
Sequence TR/TE/FA ms/ms/
degrees
Resolution (mm) Acquisition time (minutes)
Diagnostic multi-parametric image sequences
DWI, b-values: 50, 500, and 800 s/mm
2. 2300–2500/61–64 2.0×2.0×4.0 3:08
Transversal, sagittal and coronal T2-w turbo spin echo 4480–4950/103–110/120 0.6×0.6×3.0 3:22–4:43
DCE-MRI 3D T1-w spoiled gradient-echo 32/1.47/10 1.8×1.8×4.0 2:43
Image sequences during biopsy procedure
DWI, b-values: 0, 100, 500 and 800 s/mm
2. 2000/67 1.8×1.8×4.0 2:06
T2-w turbo spin echo 3620/103/120 0.8×0.8×4.0 3:26
Transversal and sagittal TRUFI image (manual technique) 4.48/2.24/70 1.1×1.1×3.0 7.5 and 8.9 s
Transversal, sagittal and coronal TRUFI image (robotic technique) 894/2.3/60 1.6×1.6×5.0 0.9 s/slice
T1-w 3D volumetric gradient echo* 4.5/2.2/43 1.0×1.0×1.0 2:20
T2-w 3D volumetric spin echo 1000/102/100 1.0×1.0×1.0 2:36
Fig. 2 Flow chart of the biopsy procedure for both the robotic and manual techniques. Scan plane adjustments were only perfomed with the IFE
software (step 4) when using the robotic technique
478 Eur Radiol (2012) 22:476–483target. To confirm correct positioning of the needle-
guide sagittal and transversal TRUFI images were
acquired through the needle-guide again. These actions
were repeated until the needle-guide was in correct
position [12].
Total procedure time and manipulation time were
recorded for both the robotic and manual techniques.
Measurements
Motion and deformation of the prostate may occur during
the biopsy procedure. This will have effect on the position
of the target. Since targeting of the CSR in both methods
was done on the images acquired in Step 2, which do not
take deformation and motion into account, it is important to
distinguish between targeting and biopsy error (Fig. 3).
Targeting error (ε) The targeting error is defined as the
normal (shortest) distance from the needle trajectory to the
original target location (Fig. 3). This error does not take
tissue deformation and patient motion into consideration.
This error is a measure for needle-guide positioning
towards the intended target.
Biopsy error (δ) The biopsy error is defined as the normal
distancefromtheneedletothetransformedtargetlocation(the
actual target location after needle insertion). The coordinates
of the transformed target are corrected for tissue deformation,
as well as patient and prostate motion. The transformed target
coordinates were calculated by adding the target displacement
vector to the original target coordinates.
Target displacement (8) The target displacement vector is
defined by the distance and angle between the original
and transformed target location. The target displacement
(φ) is the length of this vector. The 3D volumetric
images made before (Step 2) and after needle insertion
(Step 7) were used to determine the target displacement
vector. In these images identical anatomical landmarks
around the target (mean 13.7 mm; range 2.3 –
48.4 mm) were manually selected with the aid of an
open source fusion package [13]. Calcifications, benign
prostate hyperplasia (BPH) nodules, the verumontanum
and the urethra were used as anatomical landmarks. Coor-
dinatesoftheseanatomicallandmarks(≥5)wereusedtocreate
a 3D vector field. The arrows represent the direction and
distance of displacement of anatomical landmarks (Fig. 4).
The mean vector of this vector field is a quantitative measure
for localized target displacement, since anatomical landmarks
around the target were selected.
To calculate the targeting and biopsy error the needle
trajectory was determined by fitting a line through multiple
points (≥8) within the needle artifact using linear regression
in 3D-space. These points were obtained from the 3D
volumetric MR images obtained in Step 7.
Target coordinates (CSRs) were obtained from the
T 2 - wa n dD Wi m a g e sa c q u i r e di nS t e p2 .
The angle between needle trajectory and target displace-
ment direction was calculated in order to see whether the
target moved along the needle trajectory or in a random
direction (Fig. 5).
Statistical analysis
Two-tailed independent t-tests were performed to determine
whether there were significant differences between the
robotic and manual techniques for targeting error, biopsy
error, target displacement, procedure and manipulation
time. Differences were considered to be significant at
Fig. 3 Representation of the
needle inside the prostate, illus-
trating targeting error (ε), target
displacement (φ) and biopsy
error (δ). The targeting error,
defined as the normal distance
from needle to the original target
coordinate (T), is shown. Target
displacement, defined as the
distance between original target
(T) and transformed target (T′),
is represented by φ. Further-
more, the biopsy error (δ)i s
shown, which is defined as the
normal distance between trans-
formed target (T′) and needle
Eur Radiol (2012) 22:476–483 479p<.05. Statistical analysis were performed with SPSS,
version 16.0.01 (Chicago, Illinois).
Results
In total, 13 patients with 32 needle positions were analyzed.
Table 2 describes the patient characteristics and biopsy
results for both techniques.
Since the majority of previous negative TRUS-Bx had
been performed outside our institution, information on the
number of cores was not available for most patients.
Accuracy
The mean targeting error for both the robotic and manual
techniques was almost similar (5.7 vs 5.8 mm respectively,
p=0.928) (Fig. 6). The mean biopsy error was less (4.4 vs
6.5 mm) with the manual technique compared to the robotic
technique (p=0.054). Target displacement was larger with
the robotic technique (6.6 vs 6.0 mm, p=0.439).
Direction of target displacement
The mean angle between needle trajectory and target
displacement direction for the robotic and manual
techniques was 36.7° (range 4.0–82.2°) and 37.6° (range
7.7–73.3°), respectively.
Time
The mean time to perform a biopsy procedure using the
robotic technique was 76 min (range 60–100 min) and
61 min (range 52–64 min) with the manual technique.
The total procedure time includes the extra time to
acquire the 3D volumetric images (2:36 min each). The
mean manipulation time to move from target to target
was 6 min (range 3–11 min) with the robotic technique
a n d8m i n( r a n g e5 –11 min) with the manual technique.
The differences in manipulation time and procedure
time between both techniques were not significant.
Discussion
The robotic and manual techniques demonstrated com-
parable results regarding targeting error and target
displacement. The biopsy error was larger when using the
robotic technique, however not statistically significant. The
robotic technique prevented the need of moving the patient in
and out of the scanner bore for manipulation and imaging of
the needle-guide.Mostofthe targetdisplacementfoundinour
study was in the direction of the needle trajectory.
Fig. 4 3D vector field: The blue arrows represent the direction and
displacement of the anatomical landmarks. The red arrow is the mean
vector representing target displacement. Furthermore, the needle
trajectory (black line), targeting error (ε), original target (T), biopsy
error (δ) and transformed target (T′) are shown
Fig. 5 Transversal TRUFI
image through the needle guide
before (a) and after (b) needle
insertion in the prostate
480 Eur Radiol (2012) 22:476–483Several robots for transperineal seed delivery in
brachytherapy have been described in literature [14–
17]. The robotic and manual techniques for transrectal
biopsies demonstrated a larger targeting error (5.7 and
5 mm respectively) compared to other robotic techniques.
Muntener et al. found a targeting error of 2.02 mm (range
0.86–3.18 mm) with their robot in a canine model [16].
Zangos et al. describe a transgluteal approach for prostate
biopsy with a targeting error of 0.9 mm (range, 0.3–
1.6 mm) [18]. The targeting error, biopsy error and target
displacement for a transrectal biopsy device were 2.2 mm
(range 0.5–5.7 mm), 5.1 mm (range 1.6–11.0 mm) and
5.4 mm (range 1.6–11.1 mm) respectively. Although the
targeting error was less compared to our results, the
biopsy error and target displacement were in concordance
with our results [19].
MR-guided TRUS-Bx may be an alternative to
MRGBx in the future because its availability and is
probably less expensive. However, initial results show
registration errors around three millimeter in phantoms
and patients [20–23]. In addition to this error is the
targeting error and tissue deformation which together
d e t e r m i n et h ea b i l i t yt os a m p l eaC S R .
The anatomical landmarks chosen in the MR images to
determine target displacement were selected manually. This
may have introduced an error, since it is difficult to select
exactly the same position. Automatic registration would be
an alternative to diminish this error. However, automatic
registration is difficult and introduces errors as well [15].
Furthermore, the images that need to be registered are
different in the area of the target, because of the presence of
the needle, causing a line shape void in the area where best
registration is needed.
The biopsy procedures with the robotic and manual
techniques were not performed by the same radiologist. To
overcome the limitation of inter-variability, the performing
physician of each procedure performed the biopsy session
in consensus with the first author who attended all sessions.
Despite the fact that patient selection for each
technique was not randomly chosen, both groups had
similar patient characteristics (Table 2). The number of
cores taken during TRUSBx was not available for most
patients in both groups.
In the first patient a gradient-echo sequence was used
to determine needle trajectory and target displacement.
The needle artifact size was acceptable, varying from
3.5 mm to 4.5 mm. In the second patient, the angle of
the needle with the static magnetic field was larger. As
a result, the artifact size of the needle increased to
8.5 mm. Therefore, we decided to use a 3D spin-echo
sequence in which the signal void around the needle
was less influenced by distortions of the magnetic field.
Needle artifact size now varied from 3.8 to 4.7 mm.
The quantitative method described to determine target
displacement cannot discriminate between patient mo-
tion, prostate motion and tissue deformation. However,
our results demonstrated that most target displacement
was in the direction of the needle trajectory suggesting
Fig. 6 Histogram showing the mean targeting error, biopsy error and
target displacement for both the robotic and manual techniques. The
error bars represent the standard deviation
Table 2 Patient characteristics and biopsy results for both the robotic and manual techniques
Patient characteristics and biopsy results Robotic Manual
Number of patients 8 5
Number of needle placements 19 13
Median needle positions per patient 1.5 (range 1–3) 2 (range 1–4)
Mean PSA (ng/ml) 15 (range 8–28) 14 (range 7–19)
Mean prostate volume (cc) 67 (range 44–98) 72 (range 49–100)
Median number of repeated negative TRUS guided sessions. 2 (range 1–4) 2 (range 1–4)
Median lesion volume on MR images (cc) 0.85 (0.38–1.61) 0.91 (0.6–3.19)
Histopathological findings (nr. of patients) Non-malignant (3), prostatitis (3),
cancer (2)
Non-malignant (2), prostatitis (2),
cancer (1)
Eur Radiol (2012) 22:476–483 481that most of the target displacement was caused by
needle insertion.
Hambrocketal.foundamedianimagingtimeof35minfor
MRGBx [24]. In our study, we reported the total procedure
times (including patient preparation) for the robotic and
manual techniques. Although manipulation time was shorter
when using the robotic technique, the total procedure time
was longer compared to the manual technique. Positioning of
the patient was a precise and time-consuming process. In
case of incorrect positioning the whole set-up did not fit
inside the scanner bore, or the range of motion of the robotic
technique was impaired. Furthermore, a connection with the
IFE software was necessary for real-time image guidance.
Even for small adjustments in needle-guide direction, a
interaction with the IFE was necessary including manual
selection of the correct slice direction through the needle-
guide. Furthermore, some actions were only possible
from behind the MR-console (e.g. measurement tool);
the operator had to switch constantly between MR-
console and IFE monitor during the procedure. Alto-
gether this led to an extension of the procedure time.
Image registration during the biopsy procedure can correct
for target displacement and may attribute to reduce the biopsy
error [25]. Nevertheless, image registration is often a time-
consuming process. Furthermore, our results suggested that
movement of the target was mainly caused by needle
insertion. Image registration would not correct for prostate
motion due to needle insertion. Deformation models of the
prostate to predict tissue deformation due to needle insertion
may help to overcome this problem [26]. Other alternatives
are different techniques for needle insertion, such as rotating
needles and tapping devices [27–30].
Promising treatment types in the MR-scanner such as focal
cryosurgery [31] and laser ablation [32]a r en o wu n d e r
investigation. Major advantages of treatment in the MR
scanner are the ability of soft tissue imaging and monitoring
(for example temperature mapping) [33]. Robotics will play
an important role in the future during treatment in the MR
since accurate needle placement is required.
In spite of the fact that the results are comparable
regarding accuracy and speed, the larger biopsy error
and the extended technical effort of the robotic
technique make the manual technique – currently –
more suitable to perform MRGBx. Furthermore, this
study provided a better insight in displacement of the
target during in-vivo biopsy procedures.
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